Tislelizumab
BeiGene
[]
rationale 305: ph3 tislelizumab +chemo vs. chemo in naive pd-l-1 gc/gejc #gi23 
Assistant Professor, GI Onc @OSUCCC_James @EinsteinMed Alum| @ClevelandClinic Alum| Interested in Drug Development|Precision Oncology|Cancer Disparities